Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -985.17% is 60% above its 2-year average of -2437.83%, near the high end of its 2-year range (-7114.93%–-519.53%).
8.73% below its 12-month average of -906.07%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -614.15%.
EBITDA MARGIN
-985.17%
EBITDA MARGIN AVG TTM
-906.07%
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-8.73%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SeaStar Medical Holding Corporation
Market Cap
$9.10M
EBITDA Margin
-985.17%
TTM Avg
-906.07%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.22M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.47M
EBITDA Margin
-65.39%
TTM Avg
-49.20%
3Y Avg
-36.51%
5Y Avg
-25.14%
Market Cap
$9.79M
EBITDA Margin
-7418.23%
TTM Avg
-25513.08%
3Y Avg
-14528.12%
5Y Avg
-11171.17%
Market Cap
$8.32M
EBITDA Margin
-334.15%
TTM Avg
-180.95%
3Y Avg
-121.99%
5Y Avg
-121.99%
Market Cap
$10.01M
EBITDA Margin
-32.77%
TTM Avg
-184.94%
3Y Avg
-1690.71%
5Y Avg
-2111.15%
Market Cap
$8.14M
EBITDA Margin
-951.52%
TTM Avg
-1801.56%
3Y Avg
-1801.56%
5Y Avg
-1801.56%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SeaStar Medical Holding Corporation (ICU) | $9.10M | -985.17% | -906.07% | N/A | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.22M | N/A | N/A | N/A | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.34M | N/A | N/A | N/A | N/A |
| MetaVia Inc. (MTVA)vs › | $9.71M | N/A | N/A | N/A | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.47M | -65.39% | -49.20% | -36.51% | -25.14% |
| Ainos, Inc. (AIMD)vs › | $9.79M | -7418.23% | -25513.08% | -14528.12% | -11171.17% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.32M | -334.15% | -180.95% | -121.99% | -121.99% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $10.01M | -32.77% | -184.94% | -1690.71% | -2111.15% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.14M | -951.52% | -1801.56% | -1801.56% | -1801.56% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | N/A | N/A | N/A | N/A |
Gross Margin
92.6%
EBITDA Margin
-985.2%
Operating Margin
-986.6%
Net Margin
-795.5%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -614.15% |
| 2026-03-31 | -726.67% |
| 2025-12-31 | -718.10% |
| 2025-09-30 | -1951.91% |
| 2025-06-30 | -519.53% |
| 2025-03-31 | -1304.44% |
| 2024-12-31 | -7114.93% |
| 2024-09-30 | -6552.94% |
